Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-000907
Filing Date
2021-01-05
Accepted
2021-01-05 16:05:12
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211746-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm211746-2_4seq1.xml 4 8410
  Complete submission text file 0001104659-21-000907.txt   9860
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Issuer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE UNIVERSITY SQUARE DRIVE, SUITE 280 PRINCETON NJ 08540
Business Address
Westby Keith (Reporting) CIK: 0001696429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36080 | Film No.: 21505415